CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Development Officer acquired 23,804 shares (grant or award)
- 4 Grant or award Sr. Vice President and COO acquired 23,804 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 23,805 shares (grant or award)
- 8-K Event Other events
Page 9 of 24 · 469 filings